These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30467501)

  • 21. Zika virus like particles elicit protective antibodies in mice.
    Salvo MA; Kingstad-Bakke B; Salas-Quinchucua C; Camacho E; Osorio JE
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006210. PubMed ID: 29401460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein.
    Li A; Yu J; Lu M; Ma Y; Attia Z; Shan C; Xue M; Liang X; Craig K; Makadiya N; He JJ; Jennings R; Shi PY; Peeples ME; Liu SL; Boyaka PN; Li J
    Nat Commun; 2018 Aug; 9(1):3067. PubMed ID: 30076287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice.
    Jagger BW; Dowd KA; Chen RE; Desai P; Foreman B; Burgomaster KE; Himansu S; Kong WP; Graham BS; Pierson TC; Diamond MS
    J Infect Dis; 2019 Oct; 220(10):1577-1588. PubMed ID: 31260518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice.
    Lecouturier V; Bernard MC; Berry C; Carayol S; Richier E; Boudet F; Heinrichs J
    Vaccine; 2019 May; 37(20):2679-2686. PubMed ID: 30967310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid development of a DNA vaccine for Zika virus.
    Dowd KA; Ko SY; Morabito KM; Yang ES; Pelc RS; DeMaso CR; Castilho LR; Abbink P; Boyd M; Nityanandam R; Gordon DN; Gallagher JR; Chen X; Todd JP; Tsybovsky Y; Harris A; Huang YS; Higgs S; Vanlandingham DL; Andersen H; Lewis MG; De La Barrera R; Eckels KH; Jarman RG; Nason MC; Barouch DH; Roederer M; Kong WP; Mascola JR; Pierson TC; Graham BS
    Science; 2016 Oct; 354(6309):237-240. PubMed ID: 27708058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zika virus-like particle (VLP) based vaccine.
    Boigard H; Alimova A; Martin GR; Katz A; Gottlieb P; Galarza JM
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005608. PubMed ID: 28481898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections.
    Chattopadhyay A; Aguilar PV; Bopp NE; Yarovinsky TO; Weaver SC; Rose JK
    Vaccine; 2018 Jun; 36(27):3894-3900. PubMed ID: 29807712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys.
    Abbink P; Larocca RA; De La Barrera RA; Bricault CA; Moseley ET; Boyd M; Kirilova M; Li Z; Ng'ang'a D; Nanayakkara O; Nityanandam R; Mercado NB; Borducchi EN; Agarwal A; Brinkman AL; Cabral C; Chandrashekar A; Giglio PB; Jetton D; Jimenez J; Lee BC; Mojta S; Molloy K; Shetty M; Neubauer GH; Stephenson KE; Peron JP; Zanotto PM; Misamore J; Finneyfrock B; Lewis MG; Alter G; Modjarrad K; Jarman RG; Eckels KH; Michael NL; Thomas SJ; Barouch DH
    Science; 2016 Sep; 353(6304):1129-32. PubMed ID: 27492477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice.
    Wang R; Liao X; Fan D; Wang L; Song J; Feng K; Li M; Wang P; Chen H; An J
    Vaccine; 2018 Jun; 36(24):3522-3532. PubMed ID: 29753607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor.
    Dussupt V; Sankhala RS; Gromowski GD; Donofrio G; De La Barrera RA; Larocca RA; Zaky W; Mendez-Rivera L; Choe M; Davidson E; McCracken MK; Brien JD; Abbink P; Bai H; Bryan AL; Bias CH; Berry IM; Botero N; Cook T; Doria-Rose NA; Escuer AGI; Frimpong JA; Geretz A; Hernandez M; Hollidge BS; Jian N; Kabra K; Leggat DJ; Liu J; Pinto AK; Rutvisuttinunt W; Setliff I; Tran U; Townsley S; Doranz BJ; Rolland M; McDermott AB; Georgiev IS; Thomas R; Robb ML; Eckels KH; Barranco E; Koren M; Smith DR; Jarman RG; George SL; Stephenson KE; Barouch DH; Modjarrad K; Michael NL; Joyce MG; Krebs SJ
    Nat Med; 2020 Feb; 26(2):228-235. PubMed ID: 32015557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus.
    Hraber P; Bradfute S; Clarke E; Ye C; Pitard B
    Vaccine; 2018 Nov; 36(46):6911-6917. PubMed ID: 30337177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An inactivated recombinant rabies virus displaying the Zika virus prM-E induces protective immunity against both pathogens.
    Jin H; Jiao C; Cao Z; Huang P; Chi H; Bai Y; Liu D; Wang J; Feng N; Li N; Zhao Y; Wang T; Gao Y; Yang S; Xia X; Wang H
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009484. PubMed ID: 34086672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Live vaccine infection burden elicits adaptive humoral and cellular immunity required to prevent Zika virus infection.
    Yau C; Gan ES; Kwek SS; Tan HC; Ong EZ; Hamis NZ; Rivino L; Chan KR; Watanabe S; Vasudevan SG; Ooi EE
    EBioMedicine; 2020 Nov; 61():103028. PubMed ID: 33045466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Protection of Rhesus Macaques from Zika Virus Reinfection.
    Moreno GK; Newman CM; Koenig MR; Mohns MS; Weiler AM; Rybarczyk S; Weisgrau KL; Vosler LJ; Pomplun N; Schultz-Darken N; Rakasz E; Dudley DM; Friedrich TC; O'Connor DH
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization with truncated envelope protein of Zika virus induces protective immune response in mice.
    Han JF; Qiu Y; Yu JY; Wang HJ; Deng YQ; Li XF; Zhao H; Sun HX; Qin CF
    Sci Rep; 2017 Aug; 7(1):10047. PubMed ID: 28855646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NS1-based DNA vaccination confers mouse protective immunity against ZIKV challenge.
    Zhan Y; Pang Z; Du Y; Wang W; Yang Y; Wang W; Gao GF; Huang B; Deng Y; Tan W
    Infect Genet Evol; 2020 Nov; 85():104521. PubMed ID: 32882433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.
    Richner JM; Jagger BW; Shan C; Fontes CR; Dowd KA; Cao B; Himansu S; Caine EA; Nunes BTD; Medeiros DBA; Muruato AE; Foreman BM; Luo H; Wang T; Barrett AD; Weaver SC; Vasconcelos PFC; Rossi SL; Ciaramella G; Mysorekar IU; Pierson TC; Shi PY; Diamond MS
    Cell; 2017 Jul; 170(2):273-283.e12. PubMed ID: 28708997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation.
    Kim E; Erdos G; Huang S; Kenniston T; Falo LD; Gambotto A
    EBioMedicine; 2016 Nov; 13():315-320. PubMed ID: 27717627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
    Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.